Recently, we purified a new mouse T cell-derived lymphokine that we provisionally designated interleukin-HPI (HPI)' because of its growth factor activity for B cell hybridomas and plasmacytomas (1, 2). This factor, which was identified as a single chain 25-30-kD polypeptide, was subsequently found to be structurally and serologically indistinguishable from the plasmacytoma growth factors produced by macrophages and fibroblasts (3-5). Molecular cloning and sequencing of HPI cDNA (6) disclosed a very significant degree of homology with the human hybridoma growth factor, now termed interleukin 6 (7-8), that we had previously found to be identical (9) with B cell stimulatory factor 2 (10), 26-kD protein (11) and 82 (12), and that has now also been identified with the monocyte-derived hepatocyte-stimulating factor (13) .
T Cell Proliferation Assays . Spleen cells and mesenteric lymph node cells from 10-wkold female BALB/c mice were cultured in flat-bottomed microtiter wells at a cell density of 3-5 X 104 cells/well in DME supplemented with 10% FCS, L-arginine (0 .55 MM), Lasparagine (0 .24 HIM), L-glutamine (1 .5 mM), and 2-ME (50 AM) . To these cultures we added a costimulator, usually PHA, and the cytokine to be tested. Thymidine incorporation was measured in triplicate cultures on day 4 after a 6-h pulse with 0 .5 pCi methyl- [3 H] thymidine . Optimal responses to HP1/IL-6 required the use of a selected batch of PHA . The best results were obtained with PHA from Difco Laboratories Inc . (Detroit, MI) added at a final dilution of 0 .5-1 X 10 -' . The response of thymocytes was studied under similar conditions except that we used 6-wk-old mice, a 2 X 10 -s dilution of PHA, and higher cell numbers (1 .5 X 10 6 for IL-1 and 0 .5 X 10 6 for IL-2 and HP1/IL-6) . Moreover, the incubation period was reduced to 3 d.
Accessory Cell Depletion. Accessory cell depletion was obtained by passage through nylon-wool columns as described (15) and treatment with anti-I-Ad antibody MKD-6 (16) and rabbit complement (Cedarlane Laboratories, Ltd ., Hornby, Ontario, Canada) .
Induction of Cytolytic T Cell Responses. C57BL/6 (H-2°) spleen cells were incubated, in 2 ml of DME supplemented as described above, with 2 X 10 6 irradiated DBA/2 (H-2d) high-density spleen cells selected by Percoll gradient centrifugation (1 .070 < p <1 .088) . This procedure was adopted to reduce the number of macrophages and thus the levels of endogenous HP1/IL-6 in the cultures . Cytolytic activity was measured in a conventional chromium-release assay using P815 mastocytoma (H-2d ) and EL 4 thymoma (H-2 6) as target cells .
Helper T Cell Lines. Helper T cell lines were established from mice immunized with keyhole limpet hemocyanin or human transferrin as described (1) . The cell lines were routinely grown with irradiated spleen cells and antigen but without addition of exogenous growth factors . Before use in proliferation assays, the T cells were separated from dead cells by centrifugation over a layer of Lymphoprep (Nycomed, Oslo, Norway) .
Cytokines. Human rIL-la (17) and IL-2 (18) were gifts of Drs . P . Lomedico (Roche Research Center, Nutley, NJ) and W. Fiers (State University of Ghent, Belgium), respectively . HP1/IL-6 and L929-derived hybridoma growth factor (L-HGF) were purified to homogeneity as described earlier (1, 4) . IL-4 was partially purified from the supernatant of mouse helper T cell clone TUC2 .15 by adsorption on silicic acid, gel filtration, anion exchange, and reversed-phase HPLC . For each cytokine, 1 U of activity was defined as the amount of material required to produce half-maximal proliferation of the appropriate target cell, i .e ., hybridoma 7TD1 for HP1/IL-6 (1), Cytolytic T cell line CTLL for IL-2 (19) , and anti-IgM-stimulated B cells for IL-4 . These assays were carried out as previously described (1, 2) .
Monoclonal Antibodies. Anti-IL-4 mAb 111111 (20) was a gift of Dr . W . E . Paul (Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD) . Anti-HP1/IL-6 mAb 6114 was produced in our laboratory (14) . Anti-T cell mAbs used included : (a) anti-Thy-1 .2 antibody 3A8 also produced in our laboratory, (b) anti-T& antibody 145-2C I I (a gift of Dr. O . Leo, Laboratory of Animal Physiology, University of Brussels, Belgium) (21) , and (c) anti-L3T4 antibody GK1 .5 (22) and anti-Lyt-2 antibody 53 .6 .72 (23) . All rat mAbs were purified by affinity chromatography using mouse anti-rat is antibody MARKI (24), a gift of Dr . H . Bazin (Unit of Experimental Immunology, Catholic University of Louvain, Brussels, Belgium) .
Flow Cytometiy. Spleen cells and thymocytes were labeled with fluoresceinated GKl .5 and biotinylated 53 .6 .72 for 45 min at 4°C in 137 mM NaCl, 5 mM KCI, 0 .4 mM MgS04 , 0 .3 mM MgC12 , 5 mM glucose, 4 mM NaHCO j , 1 mM EDTA, containing penicillin (500 U/ml), streptomycin (1 pg/ml), and 5% FCS, and buffered with 1 mM phosphate (pH 7 .4) . After centrifugation, the cells were resuspended in the same medium containing phycoerythrin-conjugated streptavidin (Becton Dickinson & Co., Mountain View, CA), and incubated for another 45 min before sorting on an ATC3000 flow cytometer (ODAM, Wissembourg, France) . Aggregated and dead cells were excluded on the basis of forward angle light scatter values .
Results
General Remark . HPI/IL-6 was originally quantified on the basis of its growth factor activity for B cell hybridoma 7TD1, which requires^-1 pg/ml for half-maximal growth . It later turned out that the sensitivity of 7TD1 was much higher than that of other HPl/IL-6-dependent cell lines. Plasmacytomas, for example, require^-100 times more HPI/IL-6 than the hybridoma cell line (2) . It should therefore be kept in mind that, as a result of this unusual sensitivity, hybridoma growth factor units of HPI/IL-6 may be misleadingly high.
Proliferation ofPeripheral T Cells in Response to HP11IL-6. HPI/IL-6 purified to homogeneity from the supernatant of helper T cell clone TUC2 .15 was found to induce a 100-fold increase in the proliferation of spleen cells exposed to submitogenic doses of PHA (Table I, Exp . 1). This response, which was quantitatively similar to that induced by IL-2 and IL-4, was saturable and required -100 hybridoma growth factor units per milliliter for half-maximal stimulation . The proliferation induced by HPI/IL-6 was completely abolished after treatment with anti-Thy-1 antibody and complement, demonstrating the T cell nature of the responding cells (Table I, Exp . 1). Cell sorting experiments indicated that both the L3T4 + and the Lyt-2 + subsets participated in this response (Fig. 1) .
TUC2.15 supernatant contains no detectable IL-2 but considerable amounts of IL-4. Therefore, we were concerned that in spite of its apparent homogeneity in silver-stained SDS polyacrylamide gels, our HPI/IL-6 preparation might still contain traces of this lymphokine that could be responsible for the observed T 
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Responding spleen cells* * 5 X 10" spleen cells were stimulated with PHA and the indicated cytokines as described in Materials and Methods. Thymidine incorporation was measured on day 4 (mean of triplicate measurements in cpm, SE <I 09'0). $ Cells treated with anti-Thy-1 .2 mAb 3A8 and complement . cell growth factor activity . Evidence against this possibility was provided by the following observations : (a) hybridoma growth factor purified from supernatants of L cells (L-HGF), which produce no IL-4, was as active as HP1/IL-6 (Table I,  Exp. 2), and (b) anti-IL-4 mAb 111111, which completely inhibited the proliferative response of T cells to IL-4, had no effect on their response to HPI/IL-6 ( Fig . 2) . The involvement of other contaminants was ruled out by the observation that anti-HPI/IL-6 mAb 6B4 completely and specifically abolished the HP1/IL-6-induced T cell proliferation (Fig . 2) . Proliferation of Thymocytes in Response to HPI1IL-6 . In the presence of PHA, HPI/IL-6 induced thymocyte proliferations that were 5-10 times stronger than those obtained with IL-1 (Table II) . This observation, together with the fact that IL-1 is a potent inducer of IL-6 in human fibroblasts (9) , prompted us to examine the possible involvement of HPI/IL-6 in the response of thymocytes to IL-1 . Anti-HPI/IL-6 mAb 6114, which completely blocked the proliferation of thymocytes induced by HPI/IL-6, had, however, no significant effect on the IL-1-induced proliferation (Table III) , indicating that thymocyte activation by IL-1 is probably not mediated by HPI/IL-6 . In this context, it is noteworthy that HPI/IL-6 was also inactive in assays for IL-1 based either on the induction cultures and in cultures stimulated with HPI/IL-6 (10" U/ml, shaded bars) or IL-2 (100 U/ml, solid bars). Thymidine incorporation was measured on day 3 (mean of triplicate cultures, 1 SE). Sorted L3T4+Lyt-2 + , L3T4 + Lyt2 -, L3T4 -Lyt-2+ thymocytes were 95%, 98%, and 98% pure, respectively .
totally unresponsive to HP1/IL-6, whereas mature L3T4+ ,Lyt-2 -and L3T4 -,Lyt-2 + cells responded equally well to both cytokines (Fig. 3) .
Proliferation of Accessory Cell-depleted T Cells in Response to HP11IL-6. To examine the possible involvement of accessory cells in the responses to HP1/IL-6, we purified mesenteric T cells by sequential passages over nylon-wool columns and treatment with anti-la antibodies and complement. The cells collected at various stages of this procedure were then stimulated, in the presence or absence of HPOL-6, with a concentration of Con A that yielded maximal proliferation of unfractionated cells. The population obtained after two nylon-wool passages and two anti-Ia treatments, which consisted of >98% Thy-1 + cells, and contained <0 .2% accessory cells by nonspecific esterase staining, was totally unresponsive to this dose of Con A, indicating a rigorous depletion of accessory cells (27, 28) . As shown in Table IV , the response of these cells to Con A was almost completely restored upon addition of HP1/IL-6. Likewise, the synergistic activation of T cells by HPI/IL-6 and PHA or insolubilized anti-T3 antibodies Mesenteric lymph node cells were fractionated by one or two passages over nylon-wool columns followed by one or two treatments with anti-Ia antibodies and complement . They were then incubated (5 X 104 /well) with or without 103 U/ml of HPI/IL-6 in the presence of the indicated costimuli. Thymidine incorporation was measured on day 4 (mean of triplicate measurements, SE <I0%). * 2,ug/ml 1 1/1,000 1 2.5 wg/ml was also unaffected by accessory cell depletion (Table IV) In Vitro C57BL/6 spleen cells (2 X 10 6) were stimulated with 2 X 106 irradiated DBA/2 high-density spleen cells in the presence of HP 1/IL-6 (10' U/ml) or IL-2 (100 U/ml) as described in Materials and Methods. Cytolytic activity was measured on day 6 using 2,000 "Cr-labeled P815 or EL4 target cells. Results are expressed in lytic units per culture, one unit corresponding to the cytolytic activity required to obtain 20% specific lysis. NT, not tested . (Table V) . In the absence of any other s tested proliferated extensively in response to IL-2, but none responded to HPI/IL-6. The responses to IL-4 were intermediate, with about half the lines proliferating significantly and two showing extensive proliferation . Costimulation with PHA or the use of biastic rather than resting cells increased the responses to IL-4 but failed to induce any response to HPI/IL-6.
Stimulation of Cytolytic T Cell Differentiation by HPIfIL-6. The T cell responses to HPI/IL-6 examined so far were exclusively of proliferative nature. To evaluate the ability of HPI/IL-6 to also induce T cell differentiation, we tested its influence on the development of a primary in vitro cytolytic T cell response . As shown in Table VI , HPI/IL-6 enhanced the primary anti-H-2d cytolytic response of C57BL/6 spleen cells^-100-fold with little effect on cell recoveries. These responses were extremely specific, indicating that HPI fIL-6 stimulated the differentiation of only those CTL precursors that had been activated by a specific interaction with antigen .
Discussion
HPI/IL-6, the murine hybridoma and plasmacytoma growth factor, was found to stimulate the proliferation of mature thymic and peripheral T cells in the presence of submitogenic doses of either PHA or anti-T cell receptor antibodies . Both the L3T4+ and the Lyt-2+ T cell subsets responded to this st lation, which was completely inhibitable by an anti-HPI/I1 .-6 mAb and did apparently not require accessory cells. In addition, primary allogeneic cytolytic T cell responses were also enhanced in the presence of HPI/11, 6.
Half-maximal proliferation of mature T cells was induced with -100 pg/ml of HPI/IL-6, which is well within the physiological range, since titers equivalent to 100 ng/ml have been detected in the serum of mice injected with endotoxin (29) . This concentration is -10 times lower than that required for half-maximal stimulation of normal B cells (14) , which suggests that in spite of the original identification of HPI/IL-6 as a growth factor for transformed B cells, the primary immunological target of this molecule may be the T rather than the B lymphocyte. The observation that B cells, unlike T cells, require costimulation with IL-1 to become fully responsive to HPI/IL-6 (14) would also seem to support this idea.
T cell activation by lectins requires the presence of accessory cells (27, 28) . The observation that HPI/IL-6 could restore the response of accessory celldepleted T cells to Con A suggests that production of this molecule by macrophages (3, 29) plays a significant role in the ability of these cells to support such responses, and raises the question of the relation between HPI/IL-6 and recently described accessory cell-replacing factors (30, 31) . The mechanisms ed in T cell activation by HPI/IL- 6 have not yet been fully clarified. Preliminary experiments using anti-IL-2-R antibodies suggest that HPI/IL-6 could operate by inducing the production of IL-2 (manuscript in preparation) . However, we have not been able so far to detect any IL-2 in the supernatant of HPI/ IL-6-activated T cells.
The response of PHA-activated peripheral T cells to HPI/IL-6 was quantita-tively similar to that obtained with IL-2 and usually better than that induced by IL-4. Several observations, however, indicate that T cells are less uniformly responsive to HP1/IL-6 than to IL-2. Indeed, certain T cell subsets, such as immature thymocytes, were totally unresponsive to HP1/IL-6 under conditions where they significantly responded to IL-2. Moreover, all our helper T cell clones or lines failed to proliferate in the presence of HP1/IL-6, suggesting that cells repeatedly activated by exposure to antigen, which in our hands become increasingly responsive to IL-2 and IL-4, lose their responsiveness to HP1/IL-6. This observation suggests that, unlike IL-2, HP1/IL-6 may primarily act during the initial stages of T cell activation, which would be consistent with the finding that the number of IL-6 receptors is higher on resting than on activated human T cells (32) . Considering the wide variety of cells both within (e.g., macrophages) and outside (e.g., fibroblasts) the immune system (3, 4) that can be induced to produce HP1/IL-6 by viral infections or exposure to endotoxin, it is tempting therefore to speculate that this molecule could play a unique role in initiating T cell responses by enabling cells that do not belong to the immune system to activate T cells directly. Summary Interleukin-HP1 (HP1)/IL-6 is a 25-30-kD protein produced by macrophages, fibroblasts, and certain T cell lines. It was originally identified as a mouse growth factor for B cell hybridomas and plasmacytomas, and was recently shown to stimulate growth and differentiation of normal B cells. Here we demonstrate that, in the presence of lectins or anti-T cell receptor antibodies, HP1/ IL-6 has a growth factor activity equivalent to that of IL-2 for mature thymic and peripheral T cells of both the L3T4+ and Lyt-2 + subsets. Contrary to IL-2 and IL-4, HP1/IL-6 was, however, not capable of supporting the growth of established T cell lines. In addition to its effects on T cell proliferation, HP1/ IL-6 also enhanced the differentiation of mouse cytolytic T cell precursors in primary allogeneic mixed lymphocyte cultures .
Fractionation of responding cell populations indicated that HP1/IL-6 was capable of restoring the response of accessory cell-depleted T cells to Con A. This observation suggests that the production of HP1/IL-6 by macrophages could, at least partly, explain their role in polyclonal T cell activation .
We thank Dr. D. Godelaine for helpful discussions ; Drs . W. E. Paul, P. Lomedico, W. 1986. Purificatio n and NH2-terminal amino acid sequence of a new T-cell-derived
